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Abstract 
Background: Diabetes is a global epidemic affecting every country. Small countries, however, face distinctive chal-
lenges related to their health system governance and their ability to implement effective health systems’ reforms. 
The aim of this research was to perform a comparative assessment of existing diabetes management practices at the 
population level and explore governmental-related policy for Cyprus, Iceland, Luxembourg, Malta and Montenegro. 
This is the first time that such an evidence-based review study has been performed in the field of diabetes. The overall 
purpose was to set the agenda for health policy and inform strategic actions for small countries that can benefit from 
dealing with the diabetes epidemic at a country level.
Methods: We collected data and synthesized the evidence on dealing with diabetes for each of the five small Euro-
pean countries according to the (1) epidemiology of diabetes and other related metabolic abnormalities, (2) burden 
of diabetes status and (3) diabetes registers and national plans. We collected data by contacting Ministry representa-
tives and other bodies in each state, and by searching through publicly available information from the respective 
Ministry of Health website on strategies and policies.
Results: Diabetes rates were highest in Cyprus and Malta. National diabetes registers are present in Cyprus and Mon-
tenegro, while national diabetes plans and diabetes-specific strategies have been established in Cyprus, Malta and 
Montenegro. These three countries also offer a free holistic healthcare service to their diabetes population.
Conclusions: Multistakeholder, national diabetes plans and public health strategies are important means to provide 
direction on diabetes management and health service provision at the population level. However, political support 
is not always present, as seen for Iceland. The absence of evidence-based strategies, lack of funding for conducting 
regular health examination surveys, omission of monitoring practices and capacity scarcity are among the greatest 
challenges faced by small countries to effectively measure health outcomes. Nevertheless, we identified means of 
how these can be overcome. For example, the creation of public interdisciplinary repositories enables easily accessi-
ble data that can be used for health policy and strategic planning. Health policy-makers, funders and practitioners can 
consider the use of regular health examination surveys and other tools to effectively manage diabetes at the popula-
tion level.
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Key messages
• Most small member states have national diabetes 
plans, national registers and strategies.
• Diabetes plans exist in Cyprus, Malta and Monte-
negro, countries that have relatively higher diabetes 
prevalence rates and burden of disease compared to 
the much lower diabetes burdens in Luxembourg and 
Iceland.
• Regular health examination surveys are currently 
missing and, as part of monitoring and evaluation, 
this is something that should be considered.
Introduction
Noncommunicable diseases (NCDs) are global epidemics 
that contribute to a substantial burden related to morbid-
ity, disability and premature death. Diabetes falls within 
the top five predominating NCDs across the world, 
including  Europe [1]. In 2019, the International Diabe-
tes Federation (IDF) reported an estimated 463 million 
adults (aged 20–79 years) suffering from diabetes world-
wide, with 59 million residing in Europe [2]. By 2045, a 
15% rise in the diabetes population is expected to occur 
within Europe [2].
With the global spread of the coronavirus disease 2019 
(Covid-19) pandemic in 2020, several mitigation legis-
lations have been implemented by almost all countries 
across the globe to safeguard the health and safety of 
their populations. A number of these legislations have 
an effect on the healthcare systems and previously estab-
lished services, including diabetes screening, prevention 
and management [3]. Although it is too early to assess 
the exact impact of this pandemic on the diabetes situa-
tion across Europe, it can be predicted that the relation-
ship between diabetes and the healthcare services can 
only be negative in the near future, especially in light of 
the observed relationship between diabetes and Covid-19 
[3].
Small countries are known to face distinct challenges 
related to their health system governance and their health 
service delivery due to lack of capacity, limited resources, 
small market size and their constrained ability to imple-
ment effective health system reforms [4]. However, this 
is not always the case. Indeed, recently in the face of the 
Covid-19 pandemic, the small country of Malta proved 
to be a prototype for small and large European countries 
alike in the response to the first wave of the pandemic 
through health system preparedness and timely measures 
[5].
Recently, a common path was agreed among the 11 
Member States in the Small Countries Initiative of the 
WHO European Region [6] to foster a collaborative 
framework, to promote health and reduce health inequi-
ties. These goals were based on the alignment of priori-
ties on health policies within the European health policy 
Health 2020 framework, the development of capacity-
building infrastructure to promote health and reduce 
health inequities, the set-up of supportive and engag-
ing environments for the implementation of the goals 
and the development of a platform to share learning and 
experiences.
Considering the extend of the global diabetes epi-
demic, it was considered paramount to also explore 
this epidemic from a small-country perspective, while 
investigating how the associated population-level stra-
tegic planning can be improved. The World Bank and 
the Commonwealth define small countries or states as 
those with populations under 1.5 million. This defini-
tion together with data on the countries participating 
in the COST Action CA18218–European Burden of 
Disease Network (burden-eu) [7] allowed us to include 
Cyprus, Iceland, Luxembourg, Malta and Montenegro 
in this study. The objective of the study was to perform 
a comparative assessment of the existing diabetes situa-
tion at the population level while assessing the particu-
lar country’s governmental-related policy among these 
five small countries in Europe. The overall aim was to set 
up an agenda for health policy and strategic action for 
small countries in dealing with the diabetes epidemic at 
a country level. More broadly, the goal is to contribute to 
the overall continuous battle against the diabetes crisis by 
identifying potential solutions for small countries.
Methods
Methodology rationale
The authors are members of the CA18218–European 
Burden of Disease Network (burden-eu) CA18218 that 
focusses on mapping the burden of disease at the Euro-
pean level. Our study was based on a simple model of 
analysing the existing state of diabetes by synthesizing 
the evidence to make relevant suggestions on disease 
management and health policy for these countries. The 
methodology is split into three parts.
The first part is concerned with the context of analys-
ing  the five small European countries of Cyprus, Ice-
land, Luxembourg, Malta and Montenegro. The rationale 
behind this selection is threefold. Firstly, there is a lack 
of studies conducted at a national level in these countries 
and, hence, this provides an appropriate opportunity to 
study these. Secondly, when compared to other European 
countries, these small countries have a high prevalence 
of diabetes and, as such, it was considered appropriate to 
focus on these countries to shed light on the problem at 
hand and how it can be tackled. Thirdly, when comparing 
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small states, lessons can be learnt not only to help small 
countries but also to inform actions and decisions in 
geographically larger countries, with a more decentral-
ized decision-making system  in place, or at a regional 
level, having the same population size as that of an entire 
small-country state.
The second part of this work involves the documenta-
tion of the health-policy status for each of the five small 
European countries according to the (1) epidemiology of 
diabetes and other related metabolic abnormalities, (2) 
burden of diabetes status and (3) diabetes register and 
national plans. Our proposed study aims to contribute 
to the aforementioned effort within Health 2020 by iden-
tifying gaps, differences and similarities between these 
countries towards evidence-based health-policy planning 
and strategic action.
The third part of the study is focussed on the synthesis 
of the findings of an evidence-based proposal on diabetes 
management in the following three dimensions: (1) mon-
itoring and evaluation, which covers health examination 
surveys and their implementation in the five countries; 
(2) prevention, to draw on existing practices for public 
health diagnostic and screening practices; and (3) health 
system performance, to contextualize the impact of care 
delivery on the disease burden for each population.
A summary of the methodology protocol can be seen 
in Fig. 1.
Data sources
We collected data by contacting Ministry representa-
tives and other governmental bodies in each state, and 
searched for publicly available information from web-
sites on strategies and policies as available at the respec-
tive Ministry of Health, some health sector divisions 
and appropriate bodies, such as statistical organiza-
tions. We identified published articles originating from 
national surveys and datasets conducted in each of the 
five countries: Cyprus, Iceland, Luxembourg, Malta and 
Montenegro. When data were not available online, we 
contacted  the corresponding person who would in turn 
send us the available nonconfidential data. We searched 
for documents on national strategies, action plans and/or 
policies on NCDs and diabetes at a country level.
Data analysis
The burden of diabetes at a population level was evalu-
ated in terms of the “disability-adjusted life years” 
(DALYs) metrics as reported by the Institute for Health 
Metrics and Evaluation (IHME) in their Global Burden of 
Disease (GBD) study [8]. The same resource was used to 
evaluate each country’s profile characteristics [8]. Com-
parisons between the DALYs, years lived with disability 
(YLDs) and years of life lost (YLLs) data were performed 
for the five small countries, using the GBD Compare tool 
[9]. DALYs is an overall measure of the disease burden 
that takes into account the YLDs and the YLLs due to a 
disease, which in this case is diabetes. The importance 
of DALYs is that it provides a consistent, geographic and 
time-bound metric of population health on both mor-
bidity (YLDs) and mortality (YLLs) measures in units of 
years. The use of DALYs can assist in relative compari-
sons between countries for a specific condition to iden-
tify gaps in performance, research, health delivery or 
policy to prevent illness, disability or premature death. 
It can also be used to guide health system planning and 
public health interventions within a country for different 
Fig. 1 The research methodology
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diseases or by tracking changes for a specific disease over 
time. Epidemiological data were obtained from the lit-
erature in each of the five states for both incidence and 
prevalence per 100,000 people.
The scientific literature was reviewed by the authors 
and common frameworks were identified. The data 
were categorized according to diabetes: prevalence 
data, diabetes register, governmental strategy and pol-
icy and diabetes health care. Subsequently, the pub-
lished literature, strategies, policies and burden of 
disease data were reviewed, and an agenda for policy 
and strategy action based on the small countries expe-
rience was formulated.
Results
Table 1 shows the population characteristics of the five 
small countries in Europe that were included in the 
study according to the GBD study for 2017. Although 
all five countries have comparable life expectancy, 
intercountry variations are still observed. Cyprus 
ranked the highest in terms of diabetes mortality at the 
population level, followed by Montenegro and Malta.
Epidemiology of diabetes and other related metabolic 
abnormalities
Diabetes prevalence rates varied across the five small 
countries, with the highest rates being reported in Malta 
and Cyprus followed by Montenegro (Table  2) [10–13]. 
However, it is worth noting that the data obtained from 
surveys were conducted in different time frames as well 
as following different study protocols. For example, Mon-
tenegro’s diabetes estimate was based on a combina-
tion of data obtained from a national register under the 
patronage of the Institute of Public Health and the pri-
mary healthcare information system. A similar picture is 
observed for the prevalence of obesity, where the high-
est obesity rates among the five small countries were 
reported by Malta (Table  2) [12, 14–17]. Yet, data on 
impaired glucose regulation (impaired glucose tolerance 
or impaired fasting glucose) and the metabolic syndrome 
Table 1 Distribution of the population characteristics among the five small countries in Europe, 2017 [6]
GDP Gross domestic product
Population characteristics Cyprus Iceland Luxembourg Malta Montenegro
Population 875.9 K 337.5 K 590.5 K 434.5 K 626.3 K
GDP per capital (in $US) 31,531 47,062 97,887 36,920 15,716
Life expectancy at birth (in years) 81.85 82.85 81.65 80.95 76.5
Diabetes death ranking at a population level 5th  > 10th  > 10th 8th 6th
Table 2 Comparisons between prevalence of the different metabolic abnormalities across the five small countries in Europe
BMI Body mass index
Prevalence Cyprus Iceland Luxembourg Malta Montenegro
Type 2 diabetes 10.4% (2005) 6.72% (2005–2011) 9.8% (2016–2018) 10.4% (2014–2016) 10.2% (2014)
Obesity (BMI > 30 kg/m2) 25.5% (2008) 26.6% (2017) 19.2% (2016–2018) 34.1% (2014–2016) 25% (2016)
Impaired glucose tolerance – – 25.6% (2013–2015) – –
Impaired fasting glucose – – – 24.3% (2014–2016) –
Metabolic syndrome – – 28.0% (2008–2009) 26.3% (2014–2016) –
Fig. 2 Comparative summary of the diabetes epidemiology and official diabetes registers and plans across the five small countries in Europe
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was available only for Luxembourg and Malta (Table  2) 
[18–23].
Diabetes register and national plans
Official national diabetes registers are only present in 
Cyprus and Montenegro. Malta’s national diabetes reg-
ister is still in the pipeline. However, the Endocrinol-
ogy Department of Malta’s state hospital has an online 
database that physicians can voluntarily input diabetes 
patients’ data. This database can act as the foundation 
for the construction of a national diabetes register [24]. 
National diabetes plans have only been established in 
Cyprus, Malta and Montenegro [25, 26]. A compara-
tive summary of the official diabetes registers and plans 
across the five small countries can be observed in Fig. 2.
Cyprus
In Cyprus, diabetes is high on the health policy agenda 
due to its impact on the economy and productivity [25]. 
A national diabetes strategy (2016–2024) is in place and 
it is based on five pillars: (1) prevention, (2) early detec-
tion and care, (3) rehabilitation, (4) diabetes registry and 
(5) research. An interdisciplinary body, the National Dia-
betes Committee, has been appointed by the Ministerial 
Board in order to execute the policy of this diabetes stra-
tegic plan. There are 12 institutions carrying out research 
on diabetes on the island; the University of Nicosia, Nico-
sia General Hospital and the University of Cyprus are 
among the top three. Although the island has are no clin-
ical practice guidelines, the specialists follow European 
guidance or that of the UK. Cyprus has a high diabetes 
prevalence, but the amount of research done in the field 
is not appropriate to the needs of the population [27].
In Cyprus, individuals suffering from diabetes are enti-
tled to a holistic healthcare service that includes free 
medication and consultations.
Iceland
In Iceland, the position of diabetes within the politi-
cal agenda is a delicate one. Existing national policies 
target diabetes-related diseases and risk factors, includ-
ing obesity, overweight, physical inactivity, smoking 
and unhealthy eating, but not prevention of diabetes. In 
fact, there is no national plan for diabetes [25]. However, 
individuals diagnosed with diabetes are eligible for free 
medication with a minimal fee for check-up visits to dia-
betologists, diabetes nurses, ophthalmologists and podia-
trists. The diabetes care in Iceland follows the American 
Diabetes Association guidelines [28]. An interdiscipli-
nary working group appointed by the Minister of Health 
has recently suggested a national diabetes register for Ice-
land [29].
Luxembourg
In Luxembourg there is no diabetes-specific national 
plan but rather a general national prevention policy that 
targets the different chronic NCD risk factors, including 
diabetes, obesity and overweight, dietary habits, smok-
ing, physical inactivity and the harmful use of alcohol [25, 
30]. The “Eat Healthy and Move More 2018–2025 Action 
Plan” is an interministerial prevention strategy developed 
by the Education, Family, Sports and Health Ministries, 
with the aim of promoting a healthy diet and physical 
activity. Diabetic patients are eligible for free medica-
tion. However, there are no systematic yearly check-ups 
organized with endocrinologists or other allied health 
professionals. The patients need to organize follow-up 
consultations on their own initiative. Those opting to 
have check-up consultations will get a percentage reim-
bursement by the government for the incurred fee. In 
addition, a national plan for 2019–2023 to fight cardi-
oneurovascular diseases is being implemented, with a 
specific focus on diabetes risk.
Malta
In Malta, a national diabetes plan was set up entitled 
“Diabetes: A National Public Health Priority: 2015–2020” 
[31]. This plan complemented the already existing “Dia-
betes Shared Care Programme” [32]. This programme 
follows a multidisciplinary team effort to provide a free 
holistic care plan to the diabetes population and includes: 
regular follow-ups with a diabetes nurse, diabetologist, 
general practitioner with a special interest in diabetes, 
dietician, ophthalmologist, ophthalmic nurse and podia-
trist. Furthermore, all individuals diagnosed with diabe-
tes are entitled to free medication as well as to a limited 
amount of blood glucose monitoring strips every month. 
Additionally, there are a number of preventive strategies 
and action plans that target the different risk factors for 
diabetes including the “Healthy Weight for Life Strategy”, 
the “Noncommunicable Disease Control Strategy for 
Malta” and the “Food and Nutrition Policy and Action 
Plan for Malta”.
Montenegro
In Montenegro, a governmental “Strategy on Health-
care of People who Live with Diabetes 2016–2020” with 
Action Plan 2017–2020 is under completion [26]. The 
main objectives of this strategy are to improve the health 
of these people through effective measures, including 
early detection, control, treatment and prevention of 
associated complications. A multisectoral approach is 
in place to safeguard the adherence and maintenance of 
this strategy. A national strategy for the prevention and 
control of NCDs (2008–2020) is also set in place, includ-
ing the “Master Plan for Health System Development 
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(2015–2020)” focussing, among other things, on pri-
orities for diabetes. Montenegro has other strategies, 
including the “National Strategy for Sustainable Devel-
opment—NSSD 2016–2030” and the “Strategy for 
Healthcare Quality Improvement and Patient Safety 
2019–2023”, with both strategies targeting NCDs. Indi-
viduals with diabetes are eligible for free medication and 
healthcare services under the Compulsory Health Insur-
ance Act.
Burden of diabetes
On assessing the DALYs metric for the diabetes situation 
across the five small countries in Europe, we draw on dif-
ferences and similarities, as shown in Table 3. Montene-
gro had the highest diabetes DALYs and YLDs for 2017 
compared to the other small countries; however, Cyprus 
had the highest YLLs for the same year.
Discussion
Diabetes is a growing epidemic that gives rise to several 
different challenges and imposes a substantial burden 
on healthcare services. This has led to a number of col-
laborative reports and joint actions between countries 
and states that are members of the EU with the aim of 
addressing this epidemic [33]. Across Europe, many 
countries have introduced national diabetes plans or 
NCD strategies as part of a national effort to contain this 
epidemic. We identified a wealth of information related 
to the strategies and action plans that are related to (1) 
monitoring and evaluation aspects, (2) prevention and 
(3) health system performance.
A multistakeholder approach is key when develop-
ing such strategies, in addition to a sustainable political 
leadership [1, 34]. However, political support for a spe-
cific framework allocated only to diabetes is not always 
in place, as seen Iceland, which has  the highest gross 
domestic product (GDP) of the five small states studied. 
On the other hand, national diabetes plans are already 
established in Cyprus, Malta and Montenegro. These lat-
ter three small countries have relatively higher diabetes 
prevalence rates and burden of disease compared to a 
much lower diabetes burden in Luxembourg and Iceland. 
Nevertheless, all five small countries have an established 
preventive strategy targeting the various diabetes risk 
factors and NCDs.
Monitoring and evaluation
The key to successful NCD strategies is the continuous 
monitoring and evaluation of the situation at a popula-
tion level [1]. This is maintained by undertaking regular 
health surveys, ideally through health examination sur-
veys. Without regular updated evidence-based data, 
there will be sparse evidence on whether the strate-
gies are working efficiently and whether there is a need 
for more rigorous interventions. Conducting regular 
health examination surveys is one of the many challenges 
faced by most small countries due to the lack of human 
resources and research budget allocation. In fact, over 
the past 15 years, a national representative health exami-
nation survey covering diabetes was conducted only once 
in Cyprus and Malta, never in Iceland and Montenegro, 
while in Luxembourg health examination surveys were 
performed on a regular basis (2007–2008, 2013–2015 
and 2016–2017) [13, 35–37]. The European Health Inter-
view Survey consists of a number of health modules, 
including a self-reported medical history of diabetes, 
and is conducted every 5 years among the EU countries, 
including Iceland [38]. This type of survey depends on 
self-reporting; hence, it is prone to incorrect recall infor-
mation biases. However, it still constitutes a good source 
of information on health indicators at the population 
level, with reasonable resources.
Prevention: management plans and execution
An integrated approach is required when targeting 
chronic diseases, including diabetes [39]. Prevention is 
one of the key priorities in terms of reducing the burden 
of diabetes within the population [1]. In fact, prevention 
is one of the key pillars of the national diabetes plans 
set up by Cyprus, Malta and Montenegro [31]. Regard-
less of this focus on prevention, it is of utmost impor-
tance that such strategies are adhered to and maintained. 
Establishing multidisciplinary diabetes care protocols in 
each country may be the way forward to ensure adher-
ence to such strategies. Nonetheless, it is paramount that 
adequate human resources, infrastructure and financial 
budget allocation are present to enhance the healthcare 
services. In Montenegro, a multisectoral approach has 
been established to ensure that the strategies are adhered 
to. However, the implementation of these strategies still 
Table 3 Distribution of the burden of disease metrics for 
diabetes across the five small countries in Europe for 2017 [7]
DALYs Disability-adjusted life years,  GBD GlobalBburden of Disease,   YLDs years 
lived with disability,  YLLs  years of life lost
GBD 
burden 
of disease 
study 
(2017)
Cyprus Iceland Luxembourg Malta Montenegro
DALYs per 
100,000
1098 526.98 786.65 1172.67 1254.47
YLDs per 
100,000
600.66 429.75 639.76 776.97 847.71
YLLs per 
100,000
497.34 97.23 146.89 395.7 406.76
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presents a major challenge. The small island of Malta 
together with Cyprus have the highest DALYs burden of 
the other small countries; they both have one of the high-
est prevalence rates for both diabetes and obesity [10, 
14]. Although Malta has had a National Diabetes Plan 
in place since 2014, an official diabetes screening frame-
work is not yet present even if various recommendations 
have been suggested [10, 31, 40]. For Cyprus, the burden 
of disease data show that YLDs are very similar, about 
1.5-fold higher, to data on mortality from diabetes, which 
possible illustrates that a better diagnosis and regular 
blood glucose management of the disease can prevent 
premature deaths. For example, in Malta, it is at the dis-
cretion of the family physician or of the individual to seek 
out regular blood glucose testing and screening for dia-
betes. A similar picture is seen for Luxembourg.
Health system performance
A slight discrepancy is observed between the diabetes 
holistic management approach offered by the health-
care systems of these five small countries. The diabetes 
populations residing in Cyprus, Malta and Montenegro 
benefit from a free medication scheme as well as system-
atic check-up routines. This holistic approach is justified 
considering the high prevalence of diabetes among each 
country’s adult population. Regular follow-up enables 
early detection of complications and a reduction in the 
healthcare burden. Similarly, the diabetes population in 
Iceland has the same opportunities, but individuals incur 
a minimal fee for the check-up consultations. As Iceland 
has the highest GDP per capita of the five small coun-
tries studied here, this health regulation may be justi-
fied, especially as Iceland has not only the lowest overall 
disease burden but also the lowest burden from prema-
ture deaths attributed to diabetes, compared to the other 
small states studied. Of all the small countries in this 
study, Iceland enjoys the lowest overall diabetes’ burden 
even though it was noted that it lacks regular evidence-
based data to allow adequate monitoring of population 
health. This is in contrast to Luxembourg, which benefits 
from access to such data but still has a higher diabetes 
burden among its population. Therefore, the plan for a 
more organized diabetes management strategy in combi-
nation with better diagnostic and surveillance databases 
can complement the monitoring and control within the 
provided framework of service delivery to those small 
countries who suffer the most from diabetes.
Implications and recommendations
Small states, irrelevant of their GDP (except for Luxem-
bourg) and their health status, appear to have low pri-
orities for regular and ongoing surveys and population 
research. The potential reasons for this are multifactorial 
and include: the lack of human resources, minimal allo-
cation of grants and funding for research, different gov-
ernance priorities, among others. These  issues   hinder 
the mapping of the burden of diabetes and the associated 
evidence-based policy and strategic action plans. Con-
ducting regular health examination surveys with a low 
budget and minimal human resources can be achieved 
within small countries. Malta’s Health Examination Sur-
vey conducted by the University of Malta suggests that 
an epidemiological health examination survey target-
ing diabetes can be successfully conducted with mini-
mal resources [36]. A “toolkit for the development and 
implementation of epidemiological surveys in small 
populations” has been compiled by the University of 
Malta in collaboration with the World Health Organiza-
tion for Health Systems and Policies in Small States [41] 
to illustrate how small countries can use their minimal 
resources to conduct epidemiological population-based 
research. A public interdisciplinary repository may also 
be created where researchers can share their research 
and data. It is not uncommon that scholars conduct valu-
able studies as part of an academic endeavour, but the 
outcomes are not publicly shared with stakeholders. In 
small countries, such studies are more likely to be popu-
lation-based and, if easily accessed, the data can be used 
effectively for health policy and strategic planning. How-
ever, the mechanisms for the translation of this evidence 
into action are unclear. The collection of accurate health-
related data from healthcare facilities can be more feasi-
ble in small countries than in larger ones due to the small 
population size. On the other hand, small countries lack 
the capacity to conduct local burden of diseases stud-
ies. Therefore, the estimated DALYs obtained from the 
GBD study is a useful metric that helps policy-makers to 
identify the impact of a disease, such as diabetes, on their 
country. Additionally, policy-makers can make use of 
such administrative data collection systems when imple-
menting plans to assist with their decisions. It is, there-
fore, important that such resource metrics are brought to 
the attention of policy-makers while setting agendas for 
health policies and strategic action plans.
Another key challenge that small countries face is the 
inability to monitor and evaluate community diabe-
tes public awareness while building up the capacity to 
measure the health outcomes following interventions 
[33]. Provided that the right tools and data are estab-
lished, small countries are in a better position to imple-
ment interventions and monitor their outcomes due to 
their small population size. Awareness of diabetes and 
its associated risk factors is not an adequate stand-alone 
strategy; rather, it needs to be incorporated into multi-
sectorial interventions that also consider the environ-
ment, social status and cultural setting of the population 
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[42]. Therefore, it is of immense importance that policy-
makers work with various stakeholders, including local 
researchers, to collectively map the country-specific bur-
den of diabetes and set the agenda for population-specific 
action plans.
Study limitations
The focus was on diabetes management among small 
countries as associated with health policy and strategic 
action. This article is based on research literature freely 
available in online databases as well as on Ministry of 
Health and other releavent websites and data provided 
from the appropriate bodies in each of the countries. 
Ongoing or unpublished studies have, therefore, not 
been included. As such, the value of this work is limited 
in these countries (n = 5) and on their characteristics of 
setting health policies and implementing management 
practices on diabetes. This limitation may prevent the 
translation of the relevance or value of the current find-
ings on strategic planning and health policy on health 
promotion and disease prevention for diabetes to the 
remainder of the excluded countries (n = 6) from the 
European countries of the WHO Small Countries Initia-
tive (n = 11). Additionally, further research on address-
ing these differences could, therefore, bring more clarity 
on the importance of the context, with emphasis on fac-
tors and performance indicators of small countries in the 
European region.
We acknowledge that the article is based on the five 
small countries in Europe and that the generalizability of 
the findings to other smaller European or other countries 
may not be appropriate. Further research is merited to 
examine the transfer of knowledge across different small 
countries. Although the article is based solely on these 
five small European countries, we cannot draw any con-
clusions on differences in the country healthcare system 
and structure. A potentially useful model in future stud-
ies might be the Pandemic Risk Exposure Measurement 
(PREM) to identify factors that are associated with demo-
graphic characteristics, measures of a country’s activities 
and economic and social susceptibilities [43]. For exam-
ple, we can identify such complex variables to map the 
impact of diabetes management against the response, 
policies and strategies that a country can apply during a 
pandemic situation, such as Covid-19.
Study strengths
To our knowledge, this is the first study that has focussed 
on mapping the health policy and strategy on diabe-
tes management in five small countries in Europe. The 
importance of this work is that it lays the foundation 
for a future comparative study between smaller and 
medium-sized or larger European states, and for setting 
an agenda relevant to them. By collecting and analysing 
epidemiological, burden of disease and strategy plans we 
have provided a comprehensive analysis of the health pol-
icy landscape related to diabetes. Our results point out 
the similarities and differences between these countries 
and subsequently set up an evidence-based agenda for a 
health-policy framework. Additionally, this study brings 
together evidence from multiple national sources, high-
lighting gaps in the process of health policy and strategic 
action. These can, in turn, be used by policy-makers in 
each of the countries to inform their existing processes 
and current practices on diabetes management.
Conclusions
The diabetes epidemic affects every nation including 
small countries in Europe. We identified policy docu-
ments, strategies and action plans as well as mapped the 
diabetes situation and the resources for Cyprus, Iceland, 
Luxembourg, Malta and Montenegro. Despite their small 
geographical size, we observed distinct challenges faced 
by these small countries as related to their diabetes epi-
demiology, burden of disease and diabetes registers and 
national plans. Iceland and Luxembourg have the lowest 
prevalence among the five member states, and the low-
est burden from premature deaths, despite being the 
only two member states that have no official national 
register and no national plan for diabetes. While Malta, 
Montenegro and Cyprus provide a free holistic care plan 
to patients diagnosed with diabetes, they also have the 
highest disease burden from premature mortality. These 
findings may also (a) justify the need to perform health 
examination surveys for better monitoring and evalua-
tion, (b) acknowledge gaps in the prevention aspects and 
set-up of appropriate health population priorities and (c) 
identify lack of coherent management approaches within 
the health system to support the population they serve. 
The key to mapping the burden of diabetes depends on 
up-to-date evidence-based data, appropriate infrastruc-
ture and healthcare frameworks supported by the gov-
ernance and multisectoral stakeholders. Such an agenda 
can enable the implementation of targeted health policies 
and strategic action plans to reduce the burden of diabe-
tes at the population level.
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